PENDE, ALDO
 Distribuzione geografica
Continente #
EU - Europa 15.367
AS - Asia 1.543
NA - Nord America 732
SA - Sud America 112
AF - Africa 25
OC - Oceania 4
Totale 17.783
Nazione #
IT - Italia 15.098
US - Stati Uniti d'America 679
SG - Singapore 661
CN - Cina 405
VN - Vietnam 237
FR - Francia 128
BD - Bangladesh 84
HK - Hong Kong 67
BR - Brasile 64
FI - Finlandia 41
DE - Germania 32
CA - Canada 23
AR - Argentina 22
GB - Regno Unito 18
JP - Giappone 15
CH - Svizzera 14
MX - Messico 14
IN - India 13
IQ - Iraq 9
NL - Olanda 9
ID - Indonesia 8
ZA - Sudafrica 8
SA - Arabia Saudita 7
MA - Marocco 6
PK - Pakistan 6
PY - Paraguay 6
UZ - Uzbekistan 6
EC - Ecuador 5
RU - Federazione Russa 5
VE - Venezuela 5
AU - Australia 4
CL - Cile 4
CR - Costa Rica 4
PH - Filippine 4
TR - Turchia 4
UA - Ucraina 4
AT - Austria 3
CZ - Repubblica Ceca 3
HN - Honduras 3
JO - Giordania 3
KZ - Kazakistan 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ES - Italia 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
PL - Polonia 2
RO - Romania 2
SE - Svezia 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
HT - Haiti 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
LY - Libia 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 17.783
Città #
Genova 9.560
Genoa 3.218
Rapallo 1.218
Vado Ligure 955
Singapore 327
San Jose 244
Lauterbourg 123
Ho Chi Minh City 67
Ashburn 66
Hong Kong 66
Beijing 62
Hanoi 59
New York 56
Bordighera 51
Helsinki 41
Frankfurt am Main 27
Santa Clara 27
Haiphong 16
Buffalo 15
Zurich 14
Council Bluffs 13
Tokyo 12
Mexico City 11
Los Angeles 10
Da Nang 9
Guangzhou 9
Orem 9
Tianjin 9
Chicago 6
São Paulo 6
Amsterdam 5
Baghdad 5
Boardman 5
Can Tho 5
Dallas 5
Milan 5
Rome 5
Tashkent 5
Biên Hòa 4
City of London 4
Florence 4
Johannesburg 4
Nha Trang 4
San José 4
Shanghai 4
Shenzhen 4
Toledo 4
Ahmedabad 3
Amman 3
Atlanta 3
Curitiba 3
Denver 3
Detroit 3
Dhaka 3
Jeddah 3
Marrakesh 3
Montesilvano Marina 3
Montreal 3
Naples 3
Nuremberg 3
Phoenix 3
Phủ Lý 3
Poplar 3
Prague 3
Rio de Janeiro 3
San Carlo Canavese 3
Surat 3
Toronto 3
Albuquerque 2
Astana 2
Asunción 2
Bari 2
Barra 2
Basingstoke 2
Belford Roxo 2
Belo Horizonte 2
Bologna 2
Brooklyn 2
Campinas 2
Cao Lanh 2
Casablanca 2
Changsha 2
Charlotte 2
Ciserano 2
Cleveland 2
Des Moines 2
Dublin 2
Houston 2
Hải Dương 2
Jacksonville 2
Karachi 2
Kyiv 2
London 2
Louisville 2
Marseille 2
Medan 2
Merlo 2
Mississauga 2
Montevideo 2
Monticelli d'Ongina 2
Totale 16.509
Nome #
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 272
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 225
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 225
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 219
Lipoproteins, stroke and statins. 217
Clorhexidine prevents hypoclorous acid-induced inactivation of alpha1-antitrypsin. 214
Angiotensin II receptor antagonists in acute coronary syndromes. 212
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 210
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 208
Characterization of the binding of the RNA-binding protein AUF1 to the human AT1 receptor mRNA. 197
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. 186
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 186
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. 184
Role of Neutrophils in Atherogenesis: an Update 181
Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects 180
Clinical predictors of late SARS-CoV-2 positivity in Italian internal medicine wards 177
Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. 175
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. 174
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 174
Anti-ApoA-1 auto-antibodies increase cardiovascular vulnerability. 171
Blunted response of serum aldosterone to metoclopramide in the male elderly 170
Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis 170
Inflammation in the pathophysiology of essential hypertension. 169
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 168
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. 166
Anti-inflammatory approaches to reduce acute cardiovascular events: not only benefits. 166
Plasma dopamine response to sympathetic activation in man: a biphasic pattern. 164
Carotid atherosclerotic plaque stenosis: the stabilizing role of statins. 164
HPLC with electrochemical detection of catecholamines in human plasma, a mini-review. 163
Evidence for interactions between HLA system class I and beta-adrenergic receptors in human mononuclear leukocytes. 163
Carotid ultrasonography in the assessment of cardiovascular risk 162
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 161
Agonist-mediated destabilization of human b1-adrenergic receptor mRNA: role of the 3’ untranslated region. 160
Anti-apoliprotein A-1 autoantibodies are active mediators of atherosclerotic plaque vulnerability. 160
Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis 157
Neutrophil migration towards C5a and CXCL8 is abrogated by non-steroidal anti-inflammatory drugs (NSAIDs) via the inhibition of different pathways. 154
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis 154
Cardiovascular prevention: Can we do any better? 152
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 150
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy. 150
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence 150
Yohimbine effects on blood pressure and plasma catecholamines in human hypertension 148
Update on the evidence of statin treatment to reduce plaque vulnerability. 147
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages 147
Morphine-induced TSH release in normal and hypothyroid subjects. 145
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 145
Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjects 143
Resistin exerts a beneficial role in atherosclerotic plaque inflammation by inhibiting neutrophil migration 143
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 141
Classical and new renin-angiotensin signalling in atherosclerosis. 140
Inflammation Is a Key Pathophysiological Feature of Metabolic Syndrome. 140
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. 140
Recombinant tissue plasminogen activator induces neutrophil degranulation activating PI3K/Akt- and ERK1/2-mediated pathways. 139
Adrenergic receptors: relevance to myocardial signal transduction in heart failure. 138
Regular Wine Consumption in Chronic Heart Failure: Impact on Outcomes, Quality of Life, and Circulating Biomarkers 137
Inflammatory cardiovascular risk biomarkers: update on novelties and limitations. 136
Editorial: is ischemic stroke an inflammatory disease? 134
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 134
Purification and characterization of b-adrenergic receptor mRNA-binding proteins. 132
Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk 132
Effects of blood pressure control in cardiovascular prevention 132
Effects of the H2-receptor antagonist ranitidine on anterior pituitary hormone secretion in man. 129
Evaluation of pituitary-thyroid function and prolactin secretion in healthy aged subjects. 125
Troponin elevation does not always mean cardiac ischemia. 125
Simultaneous measurement of plasma catecholamine (norepinephrine, epinephrine and dopamine) and free N-methyl dopamine (epinine) levels, by HPLC with electrochemical detection. 124
Epinine kinetics and plasma catecholamine changes following oral administration of the prodrug ibopamine in patients with chronic heart failure. 122
Characterization of RNA-binding proteins possibly involved in modulating human AT 1 receptor mRNA stability. 122
Effects of rosuvastatin on atrial fibrillation occurrence: Ancillary results of the GISSI-HF trial 120
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 120
Alpha-adrenergic control of TSH secretion in man. 118
Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNPD) and HuR for A+U-rich mRNAs. 118
Identification and intracellular localization of RNA-binding proteins involved in the modulation of the hAT1 receptor mRNA stability. 118
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 118
Myocardial-directed overexpression of the human b1-adrenergic receptor in transgenic mice. 117
Preliminary characterization of a transgenic mouse overexpressing the human b1-adrenergic receptor. 117
Regulation of the mRNA-binding protein AUF1 by activation of the b-adrenergic receptor signal transduction pathway. 117
Renin-Angiotensin antagonists: therapeutic effects beyond blood pressure control? 117
An inflammatory approach in the therapeutic choices for the prevention of atherosclerotic events 116
Measurement of conjugated catecholamines in human plasma. A low cost HPLC ECD method. 115
Evidence for adrenergic mediation of the effect of morphine on LH secretion in normal men. 115
Norepinephrine-induced plasma dopamine decrease in man: pharmacological evidence of the involvement of alpha2-adrenoceptors 115
Differential binding of p37AUF1 to beta-adrenergic receptor mRNAs. 114
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 114
Intraindividual variation of beta2-adrenergic receptors on mononuclear leukocytes and their relationships with endogenous plasma catecholamines in man. 112
Effect of clonidine on gonadotropin secretion in normal men. 111
Regulation of p37AUF1, an mRNA binding protein, in human ventricular myocardium. 111
Is the carotid plaque rupture a pivotal event in stroke pathogenesis? Update on the role of the intraplaque inflammatory processes 111
Among biomarkers of neutrophil activity, matrix metalloproteinases 8 independently predicts remission of metabolic syndrome 110
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study 110
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 110
Syndrome of inappropriate antidiuretic hormone secretion and Ibuprofen, a rare association to be considered: role of tolvaptan. 109
Neuroendocrine effects of Interferon alpha 2-a in healthy human subjects. 108
Reversed-phase HPLC separation of plasma norepinephrine, epinephrine, and dopamine with three-electrode coulimetric detection. 108
Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men. 107
ß-adrenergic receptor mediated regulation of p37AUF1, an mRNA binding protein, in DDT1-MF2 cells. 106
Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Heart Failure trial 106
Interactions between HLA system and beta-adrenergic receptors in human lymphocytes. 105
Effects of opioid substances on cAMP response to the beta-adrenergic agonist isoproterenol in human mononuclear leukocytes 105
The 3’ untranslated region of the human beta1-adrenergic receptor is necessary but not sufficient for agonist-mediated destabilization. 105
Absence of correlations between plasma catecholamine levels and mononuclear leukocyte beta2-adrenergic receptors in the elderly. 105
Totale 14.608
Categoria #
all - tutte 53.911
article - articoli 51.221
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.690
Totale 107.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 0 0 94
2021/20221.579 61 97 75 223 70 149 69 368 72 149 57 189
2022/20231.469 144 75 24 162 232 294 2 102 270 4 130 30
2023/2024749 25 128 23 76 66 95 56 81 47 14 36 102
2024/20252.247 61 172 70 134 357 228 200 326 77 114 199 309
2025/20263.783 437 132 252 273 487 405 657 199 245 360 286 50
Totale 18.066